<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39471195</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>29</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2150-1327</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><PubDate><Year>2024</Year><Season>Jan-Dec</Season></PubDate></JournalIssue><Title>Journal of primary care &amp; community health</Title><ISOAbbreviation>J Prim Care Community Health</ISOAbbreviation></Journal><ArticleTitle>Evaluating the Predictors of Persistent Long COVID Symptoms and Their Severity in COVID-19 Survivors 1 Year After Infection.</ArticleTitle><Pagination><StartPage>21501319241295686</StartPage><MedlinePgn>21501319241295686</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">21501319241295686</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1177/21501319241295686</ELocationID><Abstract><AbstractText Label="INTRODUCTION/OBJECTIVE" NlmCategory="UNASSIGNED">As the coronavirus disease 2019 (COVID-19) pandemic progressed, the virus was found to cause long-term health complications known as long COVID (LC). This study aimed to investigate LC symptom severity and the factors associated with the likelihood of persistence beyond 1&#x2009;year among COVID-19 survivors in Saudi Arabia.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This descriptive, cross-sectional, questionnaire-based study was conducted via convenience sampling between December 1, 2023, and March 1, 2024. In-person interviews were performed, and 845 individuals with persistent symptoms after acute COVID-19 were included.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Hair loss and memory impairment were the most reported symptoms. In predicting LC persistence beyond 12&#x2009;months, women were found to have higher odds of being symptomatic than men, and individuals from moderate-to-high-income households were more likely to report persistent symptoms than those from low-income households. Each additional acute COVID-19 symptom increased the likelihood of persistent symptoms by 1.14 times. Reporting more symptoms in the first 6&#x2009;months post-infection significantly reduced the odds of long-term symptoms by approximately 30%.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">LC symptom severity varies among patients, and sociodemographic and clinical factors influence the likelihood of experiencing symptoms beyond 1&#x2009;year. Understanding these factors can provide insights and help optimize management, leading to improved patient outcomes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Aldhawyan</LastName><ForeName>Adam F</ForeName><Initials>AF</Initials><Identifier Source="ORCID">0000-0002-5066-2243</Identifier><AffiliationInfo><Affiliation>Department of Family and Community Medicine, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>BuSaad</LastName><ForeName>Mohammed A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Family and Community Medicine, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alamri</LastName><ForeName>Bothayna A</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alsaihati</LastName><ForeName>Mohammed I</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alanazi</LastName><ForeName>Bader S</ForeName><Initials>BS</Initials><AffiliationInfo><Affiliation>College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alanazi</LastName><ForeName>Rawan A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Department of Family and Community Medicine, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bahamdan</LastName><ForeName>Ahmed S</ForeName><Initials>AS</Initials><Identifier Source="ORCID">0000-0003-0149-077X</Identifier><AffiliationInfo><Affiliation>Department of Family and Community Medicine, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Prim Care Community Health</MedlineTA><NlmUniqueID>101518419</NlmUniqueID><ISSNLinking>2150-1319</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012529" MajorTopicYN="N" Type="Geographic">Saudi Arabia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017741" MajorTopicYN="Y">Survivors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="Y">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000505" MajorTopicYN="N">Alopecia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008569" MajorTopicYN="N">Memory Disorders</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">severity</Keyword><Keyword MajorTopicYN="N">symptoms</Keyword></KeywordList><CoiStatement>Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>29</Day><Hour>22</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>29</Day><Hour>22</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>29</Day><Hour>13</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39471195</ArticleId><ArticleId IdType="pmc">PMC11528748</ArticleId><ArticleId IdType="doi">10.1177/21501319241295686</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Reid M, Abdool-Karim Q, Geng E, Goosby E. How will COVID-19 transform global health post-pandemic? Defining research and investment opportunities and priorities. PLoS Med. 2021;18(3):e1003564. doi:10.1371/JOURNAL.PMED.1003564</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/JOURNAL.PMED.1003564</ArticleId><ArticleId IdType="pmc">PMC7951893</ArticleId><ArticleId IdType="pubmed">33705396</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizrahi B, Sudry T, Flaks-Manov N, et al.. Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study. BMJ. 2023;380: Article e072529. doi:10.1136/BMJ-2022-072529</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/BMJ-2022-072529</ArticleId><ArticleId IdType="pmc">PMC9832503</ArticleId><ArticleId IdType="pubmed">36631153</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V, Elghazaly H, Chattopadhyay R, et al.. Risk factors associated with post-COVID-19 condition: a systematic review and meta-analysis. JAMA Intern Med. 2023;183(6):566. doi:10.1001/JAMAINTERNMED.2023.0750</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/JAMAINTERNMED.2023.0750</ArticleId><ArticleId IdType="pmc">PMC10037203</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId></ArticleIdList></Reference><Reference><Citation>Trougakos IP, Stamatelopoulos K, Terpos E, et al.. Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications. J Biomed Sci. 2021;28(1):9. doi:10.1186/S12929-020-00703-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S12929-020-00703-5</ArticleId><ArticleId IdType="pmc">PMC7801873</ArticleId><ArticleId IdType="pubmed">33435929</ArticleId></ArticleIdList></Reference><Reference><Citation>Peiris S, Mesa H, Aysola A, et al.. Pathological findings in organs and tissues of patients with COVID-19: a systematic review. PLoS One. 2021;16(4): Article e0250708. doi:10.1371/JOURNAL.PONE.0250708</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/JOURNAL.PONE.0250708</ArticleId><ArticleId IdType="pmc">PMC8081217</ArticleId><ArticleId IdType="pubmed">33909679</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston C, Hughes H, Lingard S, Hailey S, Healy B. Immunity and infectivity in covid-19. BMJ. 2022;378: Article e061402. doi:10.1136/BMJ-2020-061402</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/BMJ-2020-061402</ArticleId><ArticleId IdType="pubmed">35777812</ArticleId></ArticleIdList></Reference><Reference><Citation>Filip R, Gheorghita Puscaselu R, Anchidin-Norocel L, Dimian M, Savage WK. Global challenges to public health care systems during the COVID-19 pandemic: a review of pandemic measures and problems. J Pers Med. 2022;12(8):1295. doi:10.3390/JPM12081295</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/JPM12081295</ArticleId><ArticleId IdType="pmc">PMC9409667</ArticleId><ArticleId IdType="pubmed">36013244</ArticleId></ArticleIdList></Reference><Reference><Citation>Yaseen ASA. Impact of social determinants on COVID-19 infections: a comprehensive study from Saudi Arabia governorates. Humanit Soc Sci Commun. 2022;9(1):355. doi:10.1057/s41599-022-01208-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1057/s41599-022-01208-2</ArticleId><ArticleId IdType="pmc">PMC9540145</ArticleId><ArticleId IdType="pubmed">36249903</ArticleId></ArticleIdList></Reference><Reference><Citation>Alnasser AHA, Al-Tawfiq JA, Al Kalif MSH, et al.. Impact of COVID-19 severity on health-related quality of life among Saudi adult patients. Infez Med. 2022;30(2):223-230. doi:10.53854/liim-3002-7</Citation><ArticleIdList><ArticleId IdType="doi">10.53854/liim-3002-7</ArticleId><ArticleId IdType="pmc">PMC9177185</ArticleId><ArticleId IdType="pubmed">35693056</ArticleId></ArticleIdList></Reference><Reference><Citation>Alanazi MQ, Abdelgawwad W, Almangour TA, Mostafa F, Almuheed M. Impact of COVID-19 on the health-related quality of life of patients during infection and after recovery in saudi Arabia. Int J Environ Res Public Health. 2023;20(6):5026. doi:10.3390/ijerph20065026</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph20065026</ArticleId><ArticleId IdType="pmc">PMC10049034</ArticleId><ArticleId IdType="pubmed">36981935</ArticleId></ArticleIdList></Reference><Reference><Citation>National Academies of Sciences E and M. A Long COVID Definition: A Chronic, Systemic Disease State With Profound Consequences. National Academies Press; 2024. doi:10.17226/27768</Citation><ArticleIdList><ArticleId IdType="doi">10.17226/27768</ArticleId><ArticleId IdType="pubmed">39110819</ArticleId></ArticleIdList></Reference><Reference><Citation>
CDC. Long COVID Basics | COVID-19 | CDC. Accessed July 11, 2024. https://www.cdc.gov/covid/long-term-effects/?CDC_AAref_Val=https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html</Citation></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al.. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626. doi:10.1038/S41591-021-01292-Y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41591-021-01292-Y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Sivan M, Delaney B, Evans R, Milne R. Long covid: an update for primary care. BMJ. 2022;378: Article e072117. doi:10.1136/BMJ-2022-072117</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/BMJ-2022-072117</ArticleId><ArticleId IdType="pubmed">36137612</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al.. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11(1):1-12. doi:10.1038/s41598-021-95565-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid&#x2014;mechanisms, risk factors, and management. BMJ. 2021;374: Article n1648. doi:10.1136/BMJ.N1648</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/BMJ.N1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Orr&#xf9; G, Bertelloni D, Diolaiuti F, et al.. Long-COVID syndrome? A study on the persistence of neurological, psychological and physiological symptoms. Healthcare (Basel). 2021;9(5):575. doi:10.3390/HEALTHCARE9050575</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/HEALTHCARE9050575</ArticleId><ArticleId IdType="pmc">PMC8152255</ArticleId><ArticleId IdType="pubmed">34068009</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya AA, Akbari A, Emami A, et al.. Long COVID syndrome-associated brain fog. J Med Virol. 2022;94(3):979-984. doi:10.1002/JMV.27404</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JMV.27404</ArticleId><ArticleId IdType="pmc">PMC8662118</ArticleId><ArticleId IdType="pubmed">34672377</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishna B, Wills M, Sithole N. Long COVID: what is known and what gaps need to be addressed. Br Med Bull. 2023;147(1):6-19. doi:10.1093/BMB/LDAD016</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/BMB/LDAD016</ArticleId><ArticleId IdType="pmc">PMC10502447</ArticleId><ArticleId IdType="pubmed">37434326</ArticleId></ArticleIdList></Reference><Reference><Citation>de P&#xe1;dua Serafim A, Saffi F, Soares ARA, et al.. Cognitive performance of post-covid patients in mild, moderate, and severe clinical situations. BMC Psychol. 2024;12(1):236. doi:10.1186/S40359-024-01740-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S40359-024-01740-7</ArticleId><ArticleId IdType="pmc">PMC11046800</ArticleId><ArticleId IdType="pubmed">38671529</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M, Manoharan L, Elkheir N, et al.. Characterising long COVID: a living systematic review. BMJ Glob Health. 2021;6(9): Article e005427. doi:10.1136/BMJGH-2021-005427</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/BMJGH-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Natarajan A, Shetty A, Delanerolle G, et al.. A systematic review and meta-analysis of long COVID symptoms. Syst Rev. 2023;12(1):88. doi:10.1186/S13643-023-02250-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S13643-023-02250-0</ArticleId><ArticleId IdType="pmc">PMC10220332</ArticleId><ArticleId IdType="pubmed">37245047</ArticleId></ArticleIdList></Reference><Reference><Citation>Leitner M, P&#xf6;tz G, Berger M, Fellner M, Spat S, Koini M. Characteristics and burden of acute COVID-19 and long-COVID: demographic, physical, mental health, and economic perspectives. PLoS One. 2024;19(1): Article e0297207. doi:10.1371/JOURNAL.PONE.0297207</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/JOURNAL.PONE.0297207</ArticleId><ArticleId IdType="pmc">PMC10802963</ArticleId><ArticleId IdType="pubmed">38252638</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C, Pellicer-Valero OJ, Navarro-Pardo E, et al.. Symptoms experienced at the acute phase of SARS-CoV-2 infection as risk factor of long-term post-COVID symptoms: the LONG-COVID-EXP-CM multicenter study. Int J Infect Dis. 2022;116:241-244. doi:10.1016/J.IJID.2022.01.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.IJID.2022.01.007</ArticleId><ArticleId IdType="pmc">PMC8743274</ArticleId><ArticleId IdType="pubmed">35017102</ArticleId></ArticleIdList></Reference><Reference><Citation>Arjun MC, Singh AK, Pal D, et al.. Characteristics and predictors of Long COVID among diagnosed cases of COVID-19. PLoS One. 2022;17(12): Article e0278825. doi:10.1371/JOURNAL.PONE.0278825</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/JOURNAL.PONE.0278825</ArticleId><ArticleId IdType="pmc">PMC9767341</ArticleId><ArticleId IdType="pubmed">36538532</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. J Infect Dis. 2022;226(9):1593-1607. doi:10.1093/INFDIS/JIAC136</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/INFDIS/JIAC136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>AlRadini FA, Alamri F, Aljahany MS, et al.. Post-acute COVID-19 condition in Saudi Arabia: a national representative study. J Infect Public Health. 2022;15(5):526-532. doi:10.1016/J.JIPH.2022.03.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JIPH.2022.03.013</ArticleId><ArticleId IdType="pmc">PMC8949843</ArticleId><ArticleId IdType="pubmed">35429791</ArticleId></ArticleIdList></Reference><Reference><Citation>Khodeir MM, Shabana HA, Rasheed Z, et al.. COVID-19: post-recovery long-term symptoms among patients in Saudi Arabia. PLoS One. 2021;16(12): Article e0260259. doi:10.1371/JOURNAL.PONE.0260259</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/JOURNAL.PONE.0260259</ArticleId><ArticleId IdType="pmc">PMC8654233</ArticleId><ArticleId IdType="pubmed">34879074</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkodaymi MS, Omrani OA, Fawzy NA, et al.. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis. Clin Microbiol Infect. 2022;28(5):657-666. doi:10.1016/J.CMI.2022.01.014/ATTACHMENT/26F800C8-1151-4B4E-9F27-500BDAE48654/MMC1.DOCX</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.CMI.2022.01.014/ATTACHMENT/26F800C8-1151-4B4E-9F27-500BDAE48654/MMC1.DOCX</ArticleId><ArticleId IdType="pmc">PMC8812092</ArticleId><ArticleId IdType="pubmed">35124265</ArticleId></ArticleIdList></Reference><Reference><Citation>NICE. 1 Identification | COVID-19 rapid guideline: managing the long-term effects of COVID-19 | Guidance | NICE. 2024.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Scharf RE, Anaya JM, Scharf RE, Anaya JM. Post-COVID syndrome in adults: an overview. Viruses. 2023;15(3):675. doi:10.3390/V15030675</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/V15030675</ArticleId><ArticleId IdType="pmc">PMC10056158</ArticleId><ArticleId IdType="pubmed">36992384</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmoud N, Radwan N, Alkattan A, et al.. Post-COVID-19 syndrome: nature of symptoms and associated factors. J Public Health. 2024;32(2):207-212. doi:10.1007/S10389-022-01802-3/TABLES/3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S10389-022-01802-3/TABLES/3</ArticleId><ArticleId IdType="pmc">PMC9809515</ArticleId><ArticleId IdType="pubmed">36619479</ArticleId></ArticleIdList></Reference><Reference><Citation>Morioka S, Tsuzuki S, Maruki T, et al.. Epidemiology of post-COVID conditions beyond 1 year: a cross-sectional study. Public Health. 2023;216:39-44. doi:10.1016/J.PUHE.2023.01.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.PUHE.2023.01.008</ArticleId><ArticleId IdType="pubmed">36791649</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, et al.. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. 2022;28(8):1706-1714. doi:10.1038/s41591-022-01909-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas M, Rodr&#xed;guez Y, Acosta-Ampudia Y, et al.. Autoimmunity is a hallmark of post-COVID syndrome. J Transl Med. 2022;20(1):1-5. doi:10.1186/S12967-022-03328-4/TABLES/1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S12967-022-03328-4/TABLES/1</ArticleId><ArticleId IdType="pmc">PMC8924736</ArticleId><ArticleId IdType="pubmed">35296346</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortona E, Buonsenso D, Carfi A, et al.. Long COVID: an estrogen-associated autoimmune disease? Cell Death Discov. 2021;7(1):1-3. doi:10.1038/s41420-021-00464-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41420-021-00464-6</ArticleId><ArticleId IdType="pmc">PMC8042352</ArticleId><ArticleId IdType="pubmed">33850105</ArticleId></ArticleIdList></Reference><Reference><Citation>Barsky AJ, Peekna HM, Borus JF. Somatic symptom reporting in women and men. J Gen Intern Med. 2001;16(4):266. doi:10.1046/J.1525-1497.2001.00229.X</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/J.1525-1497.2001.00229.X</ArticleId><ArticleId IdType="pmc">PMC1495200</ArticleId><ArticleId IdType="pubmed">11318929</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M, Elliott J, Chadeau-Hyam M, et al.. Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat Commun. 2022;13(1):1-10. doi:10.1038/s41467-022-29521-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29521-z</ArticleId><ArticleId IdType="pmc">PMC9005552</ArticleId><ArticleId IdType="pubmed">35413949</ArticleId></ArticleIdList></Reference><Reference><Citation>Aghili SMM, Ebrahimpur M, Arjmand B, et al.. Obesity in COVID-19 era, implications for mechanisms, comorbidities, and prognosis: a review and meta-analysis. Int J Obes. 2021;45(5):998-1016. doi:10.1038/s41366-021-00776-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41366-021-00776-8</ArticleId><ArticleId IdType="pmc">PMC7909378</ArticleId><ArticleId IdType="pubmed">33637951</ArticleId></ArticleIdList></Reference><Reference><Citation>Falsetti L, Zaccone V, Santoro L, et al.. The relationship between post-COVID syndrome and the burden of comorbidities assessed using the Charlson Comorbidity Index. Medicina (B Aires). 2023;59(9):1583. doi:10.3390/medicina59091583</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina59091583</ArticleId><ArticleId IdType="pmc">PMC10533175</ArticleId><ArticleId IdType="pubmed">37763702</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y, Liu Y, Zheng H, Liu L. Risk factors for long COVID in older adults. Biomedicines. 2023;11(11):3002. doi:10.3390/biomedicines11113002</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines11113002</ArticleId><ArticleId IdType="pmc">PMC10669899</ArticleId><ArticleId IdType="pubmed">38002002</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabiee Rad M, Abbasi M, Salimian E, et al.. Baseline socioeconomic status predicting post-COVID-19 symptoms: results from Isfahan COVID Cohort (ICC) study. Prev Med Rep. 2024;45:102814. doi:10.1016/J.PMEDR.2024.102814</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.PMEDR.2024.102814</ArticleId><ArticleId IdType="pmc">PMC11283077</ArticleId><ArticleId IdType="pubmed">39070708</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukkahatai N, Rodney T, Ling C, Daniel B, Han HR. Long COVID in the context of social determinants of health. Front Public Health. 2023;11: Article 1098443. doi:10.3389/FPUBH.2023.1098443</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FPUBH.2023.1098443</ArticleId><ArticleId IdType="pmc">PMC10088562</ArticleId><ArticleId IdType="pubmed">37056649</ArticleId></ArticleIdList></Reference><Reference><Citation>McMaughan DJ, Oloruntoba O, Smith ML. Socioeconomic status and access to healthcare: interrelated drivers for healthy aging. Front Public Health. 2020;8:512143. doi:10.3389/FPUBH.2020.00231/BIBTEX</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FPUBH.2020.00231/BIBTEX</ArticleId><ArticleId IdType="pmc">PMC7314918</ArticleId><ArticleId IdType="pubmed">32626678</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M, Palese A, Venturini M, et al.. Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin Microbiol Infect. 2021;27(10):1507-1513. doi:10.1016/j.cmi.2021.05.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.05.033</ArticleId><ArticleId IdType="pmc">PMC8180450</ArticleId><ArticleId IdType="pubmed">34111579</ArticleId></ArticleIdList></Reference><Reference><Citation>Durstenfeld MS, Peluso MJ, Peyser ND, et al.. Factors associated with long COVID symptoms in an online cohort study. Open Forum Infect Dis. 2023;10(2): Article ofad047. doi:10.1093/OFID/OFAD047</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/OFID/OFAD047</ArticleId><ArticleId IdType="pmc">PMC9945931</ArticleId><ArticleId IdType="pubmed">36846611</ArticleId></ArticleIdList></Reference><Reference><Citation>Surapaneni KM, Singhal M, Saggu SR, Bhatt A, Shunmathy P, Joshi A. A scoping review on long COVID-19: physiological and psychological symptoms post-acute, long-post and persistent post COVID-19. Healthcare. 2022;10(12):2418. doi:10.3390/HEALTHCARE10122418</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/HEALTHCARE10122418</ArticleId><ArticleId IdType="pmc">PMC9778115</ArticleId><ArticleId IdType="pubmed">36553942</ArticleId></ArticleIdList></Reference><Reference><Citation>Vos T, Hanson SW, Abbafati C, et al.. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA. 2022;328(16):1604-1615. doi:10.1001/JAMA.2022.18931</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/JAMA.2022.18931</ArticleId><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, et al.. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38: Article 101019. doi:10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Jangnin R, Ritruangroj W, Kittisupkajorn S, et al.. Long-COVID prevalence and its association with health outcomes in the post-vaccine and antiviral-availability era. J Clin Med. 2024;13(5):1208. doi:10.3390/JCM13051208</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/JCM13051208</ArticleId><ArticleId IdType="pmc">PMC10931928</ArticleId><ArticleId IdType="pubmed">38592016</ArticleId></ArticleIdList></Reference><Reference><Citation>de Miranda DAP, Gomes SVC, Filgueiras PS, et al.. Long COVID-19 syndrome: a 14-months longitudinal study during the two first epidemic peaks in Southeast Brazil. Trans R Soc Trop Med Hyg. 2022;116(11):1007-1014. doi:10.1093/trstmh/trac030</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/trstmh/trac030</ArticleId><ArticleId IdType="pubmed">35514142</ArticleId></ArticleIdList></Reference><Reference><Citation>Byambasuren O, Stehlik P, Clark J, Alcorn K, Glasziou P. Effect of covid-19 vaccination on long covid: systematic review. BMJ Med. 2023;2(1):e000385. doi:10.1136/BMJMED-2022-000385</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/BMJMED-2022-000385</ArticleId><ArticleId IdType="pmc">PMC9978692</ArticleId><ArticleId IdType="pubmed">36936268</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Bosworth ML, King S, et al.. Risk of long COVID in people infected with severe acute respiratory syndrome coronavirus 2 after 2 doses of a coronavirus disease 2019 vaccine: community-based, matched cohort study. Open Forum Infect Dis. 2022;9(9):ofac464. doi:10.1093/OFID/OFAC464</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/OFID/OFAC464</ArticleId><ArticleId IdType="pmc">PMC9494414</ArticleId><ArticleId IdType="pubmed">36168555</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Penfold RS, Merino J, et al.. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID symptom study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis. 2022;22(1):43-55. doi:10.1016/S1473-3099(21)00460-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00460-6</ArticleId><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat Med. 2022;28(7):1461-1467. doi:10.1038/s41591-022-01840-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Harrison PJ. Six-month sequelae of post-vaccination SARS-CoV-2 infection: a retrospective cohort study of 10,024 breakthrough infections. Brain Behav Immun. 2022;103:154-162. doi:10.1016/J.BBI.2022.04.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.BBI.2022.04.013</ArticleId><ArticleId IdType="pmc">PMC9013695</ArticleId><ArticleId IdType="pubmed">35447302</ArticleId></ArticleIdList></Reference><Reference><Citation>Strain WD, Sherwood O, Banerjee A, Van der Togt V, Hishmeh L, Rossman J. The impact of COVID vaccination on symptoms of long COVID: an international survey of people with lived experience of long COVID. Vaccines. 2022;10(5):652. doi:10.3390/VACCINES10050652</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/VACCINES10050652</ArticleId><ArticleId IdType="pmc">PMC9146071</ArticleId><ArticleId IdType="pubmed">35632408</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei J, Pouwels KB, Stoesser N, et al.. SARS-CoV-2 anti-spike IgG antibody responses after second dose of ChAdOx1 or BNT162b2 and correlates of protection in the UK general population. medRxiv. Published online November 15, 2021. doi:10.1101/2021.09.13.21263487</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.09.13.21263487</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller-Ramos P, Ianhez M, Silva de, Castro CC, Talhari C, Criado PR, Amante Miot H. Post-COVID-19 hair loss: prevalence and associated factors among 5,891 patients. Int J Dermatol. 2022;61(5):e162-e164. doi:10.1111/IJD.16041</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/IJD.16041</ArticleId><ArticleId IdType="pubmed">35080250</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Li Y, Liu L, et al.. Infection of human sweat glands by SARS-CoV-2. Cell Discov. 2020;6(1):1-3. doi:10.1038/s41421-020-00229-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-020-00229-y</ArticleId><ArticleId IdType="pmc">PMC7661176</ArticleId><ArticleId IdType="pubmed">33298845</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharquie KE, Jabbar RI. COVID-19 infection is a major cause of acute telogen effluvium. Ir J Med Sci. 2022;191(4):1677-1681. doi:10.1007/S11845-021-02754-5/FIGURES/3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S11845-021-02754-5/FIGURES/3</ArticleId><ArticleId IdType="pmc">PMC8407603</ArticleId><ArticleId IdType="pubmed">34467470</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo M, Guo L, Yu M, Wang H. The psychological and mental impact of coronavirus disease 2019 (COVID-19) on medical staff and general public: a systematic review and meta-analysis. Psychiatry Res. 2020;291:113190. doi:10.1016/J.PSYCHRES.2020.113190</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.PSYCHRES.2020.113190</ArticleId><ArticleId IdType="pmc">PMC7276119</ArticleId><ArticleId IdType="pubmed">32563745</ArticleId></ArticleIdList></Reference><Reference><Citation>Rebora A. Telogen effluvium: a comprehensive review. Clin Cosmet Investig Dermatol. 2019;12:583-590. doi:10.2147/CCID.S200471</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CCID.S200471</ArticleId><ArticleId IdType="pmc">PMC6709511</ArticleId><ArticleId IdType="pubmed">31686886</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xf8;raas A, B&#xf8; R, Kalleberg KT, St&#xf8;er NC, Ellingjord-Dale M, Landr&#xf8; NI. Self-reported memory problems 8 months after COVID-19 infection. JAMA Netw Open. 2021;4(7):e2118717. doi:10.1001/JAMANETWORKOPEN.2021.18717</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/JAMANETWORKOPEN.2021.18717</ArticleId><ArticleId IdType="pmc">PMC8322992</ArticleId><ArticleId IdType="pubmed">34323987</ArticleId></ArticleIdList></Reference><Reference><Citation>Premraj L, Kannapadi NV, Briggs J, et al.. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: a meta-analysis. J Neurol Sci. 2022;434:120162. doi:10.1016/J.JNS.2022.120162</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JNS.2022.120162</ArticleId><ArticleId IdType="pmc">PMC8798975</ArticleId><ArticleId IdType="pubmed">35121209</ArticleId></ArticleIdList></Reference><Reference><Citation>Dekeyzer S, De Kock I, Nikoubashman O, et al.. &#x201c;Unforgettable&#x201d;: a pictorial essay on anatomy and pathology of the hippocampus. Insights Imaging. 2017;8(2):199-212. doi:10.1007/S13244-016-0541-2/FIGURES/27</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S13244-016-0541-2/FIGURES/27</ArticleId><ArticleId IdType="pmc">PMC5359145</ArticleId><ArticleId IdType="pubmed">28108955</ArticleId></ArticleIdList></Reference><Reference><Citation>Nouraeinejad A. Memory loss in patients with long COVID can be due to reduced hippocampal neurogenesis. Eur Arch Psychiatry Clin Neurosci. 2023;1:1-2. doi:10.1007/S00406-023-01610-0/METRICS</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S00406-023-01610-0/METRICS</ArticleId><ArticleId IdType="pmc">PMC10111313</ArticleId><ArticleId IdType="pubmed">37071159</ArticleId></ArticleIdList></Reference><Reference><Citation>Shan D, Li S, Xu R, et al.. Post-COVID-19 human memory impairment: a PRISMA-based systematic review of evidence from brain imaging studies. Front Aging Neurosci. 2022;14:1077384. doi:10.3389/FNAGI.2022.1077384/BIBTEX</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FNAGI.2022.1077384/BIBTEX</ArticleId><ArticleId IdType="pmc">PMC9780393</ArticleId><ArticleId IdType="pubmed">36570532</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, VanElzakker MB. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front Microbiol. 2021;12:698169. doi:10.3389/FMICB.2021.698169/BIBTEX</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FMICB.2021.698169/BIBTEX</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka M, Mizuno K, Yamaguti K, et al.. Autonomic nervous alterations associated with daily level of fatigue. Behav Brain Funct. 2011;7(1):1-6. doi:10.1186/1744-9081-7-46/FIGURES/2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1744-9081-7-46/FIGURES/2</ArticleId><ArticleId IdType="pmc">PMC3214128</ArticleId><ArticleId IdType="pubmed">22032726</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudroff T, Kamholz J, Fietsam AC, Deters JR, Bryant AD. Post-COVID-19 fatigue: potential contributing factors. Brain Sci. 2020;10(12):1012. doi:10.3390/BRAINSCI10121012</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/BRAINSCI10121012</ArticleId><ArticleId IdType="pmc">PMC7766297</ArticleId><ArticleId IdType="pubmed">33352638</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharetts R, Moein ST, Khan R, Doty RL. Long-term taste and smell outcomes after COVID-19. JAMA Netw Open. 2024;7(4): Article e247818. doi:10.1001/JAMANETWORKOPEN.2024.7818</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/JAMANETWORKOPEN.2024.7818</ArticleId><ArticleId IdType="pmc">PMC11040410</ArticleId><ArticleId IdType="pubmed">38652477</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira LA, Salzano G, Deiana G, De Riu G. Anosmia and ageusia: common findings in COVID-19 patients. Laryngoscope. 2020;130(7):1787. doi:10.1002/LARY.28692</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/LARY.28692</ArticleId><ArticleId IdType="pmc">PMC7228304</ArticleId><ArticleId IdType="pubmed">32237238</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopkins C. Presentation of new onset anosmia during the COVID-19 pandemic. Rhinol J. 2020;58(3):295-298.</Citation><ArticleIdList><ArticleId IdType="pubmed">32277751</ArticleId></ArticleIdList></Reference><Reference><Citation>Gane SB. Isolated sudden onset anosmia in COVID-19 infection. A novel syndrome? Rhinol J. 2020;58(3):299-301.</Citation><ArticleIdList><ArticleId IdType="pubmed">32240279</ArticleId></ArticleIdList></Reference><Reference><Citation>Scoppettuolo P, Borrelli S, Naeije G. Neurological involvement in SARS-CoV-2 infection: a clinical systematic review. Brain Behav Immun Health. 2020;5: Article 100094. doi:10.1016/J.BBIH.2020.100094</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.BBIH.2020.100094</ArticleId><ArticleId IdType="pmc">PMC7832728</ArticleId><ArticleId IdType="pubmed">33521692</ArticleId></ArticleIdList></Reference><Reference><Citation>Iadecola C, Anrather J, Kamel H. Effects of COVID-19 on the nervous system. Cell. 2020;183(1):16-27.e1. doi:10.1016/J.CELL.2020.08.028/ASSET/F33A3341-F4BA-453A-91BB-EF1608292FE9/MAIN.ASSETS/GR3.JPG</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.CELL.2020.08.028/ASSET/F33A3341-F4BA-453A-91BB-EF1608292FE9/MAIN.ASSETS/GR3.JPG</ArticleId><ArticleId IdType="pmc">PMC7437501</ArticleId><ArticleId IdType="pubmed">32882182</ArticleId></ArticleIdList></Reference><Reference><Citation>Han AY, Mukdad L, Long JL, Lopez IA. Anosmia in COVID-19: mechanisms and significance. Chem Senses. 2020;45(6):423-428. doi:10.1093/CHEMSE/BJAA040</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/CHEMSE/BJAA040</ArticleId><ArticleId IdType="pmc">PMC7449368</ArticleId><ArticleId IdType="pubmed">32556089</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C, Navarro-Santana M, G&#xf3;mez-Mayordomo V, et al.. Headache as an acute and post-COVID-19 symptom in COVID-19 survivors: a meta-analysis of the current literature. Eur J Neurol. 2021;28(11):3820-3825. doi:10.1111/ENE.15040</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ENE.15040</ArticleId><ArticleId IdType="pmc">PMC8444899</ArticleId><ArticleId IdType="pubmed">34327787</ArticleId></ArticleIdList></Reference><Reference><Citation>Poncet-Megemont L, Paris P, Tronchere A, et al.. High prevalence of headaches during covid-19 infection: a retrospective cohort study. Headache. 2020;60(10):2578-2582. doi:10.1111/HEAD.13923</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/HEAD.13923</ArticleId><ArticleId IdType="pmc">PMC7436456</ArticleId><ArticleId IdType="pubmed">32757419</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigues AN, Dias ARN, Paranhos ACM, et al.. Headache in long COVID as disabling condition: a clinical approach. Front Neurol. 2023;14:1149294. doi:10.3389/FNEUR.2023.1149294/BIBTEX</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FNEUR.2023.1149294/BIBTEX</ArticleId><ArticleId IdType="pmc">PMC10076861</ArticleId><ArticleId IdType="pubmed">37034080</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares-Zapatero D, Chalon P, Kohn L, et al.. Pathophysiology and mechanism of long COVID: a comprehensive review. Ann Med. 2022;54(1):1473-1487. doi:10.1080/07853890.2022.2076901</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2076901</ArticleId><ArticleId IdType="pmc">PMC9132392</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId></ArticleIdList></Reference><Reference><Citation>Wostyn P. COVID-19 and chronic fatigue syndrome: is the worst yet to come? Med Hypotheses. 2021;146:110469. doi:10.1016/J.MEHY.2020.110469</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.MEHY.2020.110469</ArticleId><ArticleId IdType="pmc">PMC7836544</ArticleId><ArticleId IdType="pubmed">33401106</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolay H, G&#xfc;l A, Baykan B. COVID-19 is a real headache! Headache. 2020;60(7):1415-1421. doi:10.1111/HEAD.13856</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/HEAD.13856</ArticleId><ArticleId IdType="pmc">PMC7272895</ArticleId><ArticleId IdType="pubmed">32412101</ArticleId></ArticleIdList></Reference><Reference><Citation>Brola W, Wilski M. Neurological consequences of COVID-19. Pharmacol Rep. 2022;74(6):1208-1222. doi:10.1007/S43440-022-00424-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S43440-022-00424-6</ArticleId><ArticleId IdType="pmc">PMC9524739</ArticleId><ArticleId IdType="pubmed">36180640</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham EL, Clark JR, Orban ZS, et al.. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 &#x201c;long haulers.&#x201d; Ann Clin Transl Neurol. 2021;8(5):1073-1085. doi:10.1002/ACN3.51350</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ACN3.51350</ArticleId><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Nittas V, Gao M, West EA, et al.. Long COVID through a public health lens: an umbrella review. Public Health Rev. 2022;43:1604501. doi:10.3389/PHRS.2022.1604501/BIBTEX</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/PHRS.2022.1604501/BIBTEX</ArticleId><ArticleId IdType="pmc">PMC8963488</ArticleId><ArticleId IdType="pubmed">35359614</ArticleId></ArticleIdList></Reference><Reference><Citation>Havervall S, Rosell A, Phillipson M, et al.. Symptoms and functional impairment assessed 8 months after mild COVID-19 among health care workers. JAMA. 2021;325(19):2015-2016. doi:10.1001/JAMA.2021.5612</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/JAMA.2021.5612</ArticleId><ArticleId IdType="pmc">PMC8027932</ArticleId><ArticleId IdType="pubmed">33825846</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M, Schommers P, Stecher M, et al.. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health Eur. 2021;6:100122. doi:10.1016/j.lanepe.2021.100122</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100122</ArticleId><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavery AM, Preston LE, Ko JY, et al.. Characteristics of hospitalized COVID-19 patients discharged and experiencing same-hospital readmission &#x2014; United States, March&#x2013;August 2020. MMWR Morb Mortal Wkly Rep. 2022;69(45):1695-1699. doi:10.15585/MMWR.MM6945E2</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/MMWR.MM6945E2</ArticleId><ArticleId IdType="pmc">PMC7660660</ArticleId><ArticleId IdType="pubmed">33180754</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnelly JP, Wang XQ, Iwashyna TJ, Prescott HC. Readmission and death after initial hospital discharge among patients with COVID-19 in a large multihospital system. JAMA. 2021;325(3):304-306. doi:10.1001/JAMA.2020.21465</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/JAMA.2020.21465</ArticleId><ArticleId IdType="pmc">PMC7737131</ArticleId><ArticleId IdType="pubmed">33315057</ArticleId></ArticleIdList></Reference><Reference><Citation>Menges D, Ballouz T, Anagnostopoulos A, et al.. Burden of post-COVID-19 syndrome and implications for healthcare service planning: a population-based cohort study. PLoS One. 2021;16(7):e0254523. doi:10.1371/JOURNAL.PONE.0254523</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/JOURNAL.PONE.0254523</ArticleId><ArticleId IdType="pmc">PMC8274847</ArticleId><ArticleId IdType="pubmed">34252157</ArticleId></ArticleIdList></Reference><Reference><Citation>Willi S, L&#xfc;thold R, Hunt A, et al.. COVID-19 sequelae in adults aged less than 50 years: a systematic review. Travel Med Infect Dis. 2021;40:101995. doi:10.1016/J.TMAID.2021.101995</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.TMAID.2021.101995</ArticleId><ArticleId IdType="pmc">PMC7898978</ArticleId><ArticleId IdType="pubmed">33631340</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang L, Yang B, Jiang N, et al.. Three-month follow-up study of survivors of coronavirus disease 2019 after discharge. J Korean Med Sci. 2020;35(47): Article e418. doi:10.3346/JKMS.2020.35.E418</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/JKMS.2020.35.E418</ArticleId><ArticleId IdType="pmc">PMC7721559</ArticleId><ArticleId IdType="pubmed">33289374</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra V, Flanders SA, O&#x2019;Malley M, Malani AN, Prescott HC. Sixty-day outcomes among patients hospitalized with COVID-19. Ann Intern Med. 2021;174(4):576-578. doi:10.7326/M20-5661</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-5661</ArticleId><ArticleId IdType="pmc">PMC7707210</ArticleId><ArticleId IdType="pubmed">33175566</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E, Janvier P, Kherabi Y, et al.. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect. 2020;81(6):e4-e6. doi:10.1016/j.jinf.2020.08.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.08.029</ArticleId><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>